SCHEMBL7364288

SCHEMBL7364288

N#Cc1cccc(CCCC(N)c2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 2/20 0.56
KCNH2 Q12809 2/20 0.56
HTR2B P41595 1/20 0.39
ALDH1A1 P00352 1/20 0.38
FOLH1 Q04609 1/20 0.37
GLA P06280 1/20 0.37
VCAM1 P19320 2/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
P4HB P07237 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.35
FBP1 P09467 1/20 0.35
CYP19A1 P11511 2/20 0.35
SIGMAR1 Q99720 1/20 0.35
EPHX1 P07099 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7364292 0.88 KCNH2 (0.53) KCNJ1KCNH2ALDH1A1VCAM1LOXL2
SCHEMBL7363755 0.85 KCNJ1 (0.54) KCNJ1KCNH2FOLH1GLAVCAM1
SCHEMBL7363757 0.76 KCNJ1 (0.51) KCNJ1KCNH2VCAM1LOXL2P4HB
SCHEMBL7365383 0.75 KCNJ1 (0.57) KCNJ1KCNH2ALDH1A1GLAP4HB
SCHEMBL7365988 0.73 KCNH2 (0.45) KCNJ1KCNH2ALDH1A1FOLH1KMT2A
SCHEMBL7453828 0.73 KCNJ1 (0.60) KCNJ1KCNH2ALDH1A1MAPTKMT2A
SCHEMBL27524576 0.72 SIGMAR1 (0.49) KCNJ1KCNH2ALDH1A1LOXL2SIGMAR1
SCHEMBL28865565 0.70 HTR2B (0.50) KCNJ1KCNH2HTR2BALDH1A1FOLH1
SCHEMBL28248372 0.70 HTR2B (0.54) KCNJ1KCNH2HTR2BALDH1A1FOLH1
SCHEMBL6690598 0.69 LOXL2 (0.52) ALDH1A1LOXL2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0892780-A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1999-01-27 EP disclosed
WO-1997030971-A1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-28 WO disclosed